As recognized by the WHO in 2016, DLBCL cases with a MYC translocation in combination with a BCL2 and/or BCL6 translocation are classified as high-grade B-cell lymphoma (HGBL) [19]. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.